The research program centers on refining radiotherapy, radiosurgery, and brachytherapy systems to achieve higher precision. By sharpening the accuracy of radiation delivery, Elekta aims to protect healthy tissue surrounding tumors, a critical requirement for treating lesions located near sensitive organs. Beyond hardware, the project allocates significant resources to software development, targeting clinical workflows that currently strain under the weight of staff shortages and rising patient volumes. Enhanced digital tools are expected to streamline treatment planning, allowing hospitals to manage more patients without compromising care standards.
Most of this innovation will occur in Sweden and the Netherlands, anchoring Elekta’s development pipeline within Europe. CFO Klara Eiritz noted that the financing provides the necessary flexibility to sustain long-term investment in clinical outcomes and operational efficiency. EIB Vice-President Karl Nehammer highlighted the strategic importance of the loan, framing it as a move to bolster Europe’s medical technology sector and maintain the continent's competitive edge in health infrastructure. The funding falls under the EIB’s TechEU program, reinforcing the European Union’s commitment to advancing industrial competitiveness in strategic health technologies.
Comments (0)
No comments yet. Be the first!